SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-025221
Filing Date
2018-04-19
Accepted
2018-04-19 16:05:42
Documents
2
Period of Report
2018-04-19
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-11244_18k.htm 8-K 32994
2 EX-99.1 a18-11244_1ex99d1.htm EX-99.1 19726
  Complete submission text file 0001104659-18-025221.txt   54021
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 18763840
SIC: 2834 Pharmaceutical Preparations